CTI BIOPHARMA Trademark

Trademark Overview

On Wednesday, August 6, 2014, a trademark application was filed for CTI BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the CTI BIOPHARMA trademark a serial number of 86978798. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, September 30, 2021. This trademark is owned by CTI BIOPHARMA CORP.. The CTI BIOPHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research, development, engineering, testing, product evaluation, and inspection in the field of pharmaceutical preparations and products; pharmaceutical research and development; providing technical consultation in the field of pharmaceutical product research and development; medical and scientific research, namely, conducting clinical trials for others for pharmaceutical preparations used for the treatment of cancer, immunological, inflammatory and infectious diseases, and pain; scientific research, consulting, and advice in the fields of biotechnology, pharmaceutical research and development, and the life sciences; pharmaceutical, medical and laboratory research services in the fields of pharmaceuticals, cancer, genetic disorders, and the life sciences; providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticals, the life sciences, clinical trials, medicine, oncology, hematology, cancer, disease classificat...
cti biopharma

General Information

Serial Number86978798
Word MarkCTI BIOPHARMA
Filing DateWednesday, August 6, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, September 30, 2021
Registration Number4980005
Registration DateTuesday, June 14, 2016
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 1, 2015

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOPHARMA"
Description of MarkThe mark consists of a stylized image of a stick figure design to the left hand side of the wording "CTI BIOPHARMA".
Goods and ServicesResearch, development, engineering, testing, product evaluation, and inspection in the field of pharmaceutical preparations and products; pharmaceutical research and development; providing technical consultation in the field of pharmaceutical product research and development; medical and scientific research, namely, conducting clinical trials for others for pharmaceutical preparations used for the treatment of cancer, immunological, inflammatory and infectious diseases, and pain; scientific research, consulting, and advice in the fields of biotechnology, pharmaceutical research and development, and the life sciences; pharmaceutical, medical and laboratory research services in the fields of pharmaceuticals, cancer, genetic disorders, and the life sciences; providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticals, the life sciences, clinical trials, medicine, oncology, hematology, cancer, disease classification, and genetic disorders; and consultation related to the foregoing

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 15, 2014
Primary Code042
First Use Anywhere DateSaturday, May 31, 2014
First Use In Commerce DateSaturday, May 31, 2014

Trademark Owner History

Party NameCTI BIOPHARMA CORP.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSEATTLE, WA 98121
Party NameCTI BIOPHARMA CORP.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121
Party NameCTI BIOPHARMA CORP.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121

Trademark Events

Event DateEvent Description
Thursday, September 30, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, September 30, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, September 30, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 16, 2021TEAS SECTION 8 & 15 RECEIVED
Monday, June 14, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, June 15, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Thursday, May 14, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 14, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 6, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 6, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 6, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 6, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 6, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 6, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 14, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, May 10, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, May 6, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 6, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, May 7, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, April 15, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, April 14, 2016STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 23, 2016USE AMENDMENT FILED
Thursday, April 14, 2016DIVISIONAL PROCESSING COMPLETE
Tuesday, February 23, 2016DIVISIONAL REQUEST RECEIVED
Tuesday, April 12, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 23, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, February 23, 2016TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, January 26, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 1, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 1, 2015PUBLISHED FOR OPPOSITION
Wednesday, November 11, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 29, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 26, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 20, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 19, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 19, 2015TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, April 29, 2015NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 29, 2015FINAL REFUSAL E-MAILED
Wednesday, April 29, 2015FINAL REFUSAL WRITTEN
Thursday, March 12, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 12, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 5, 2015ASSIGNED TO LIE
Wednesday, February 25, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, August 31, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, August 31, 2014NON-FINAL ACTION E-MAILED
Sunday, August 31, 2014NON-FINAL ACTION WRITTEN
Sunday, August 31, 2014ASSIGNED TO EXAMINER
Saturday, August 16, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, August 15, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 9, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

biopharma research pharmaceutical medical development scientific life sciences fields cancer pharmaceuticals